Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Different monocyte phenotypes result in proresolving macrophages in conjugated linoleic acid-induced attenuated progression and regression of atherosclerosis.

Bruen R, Curley S, Kajani S, Lynch G, O'Reilly ME, Dillon ET, Fitzsimons S, Mthunzi L, McGillicuddy FC, Belton O.

FASEB J. 2019 Jul 5:fj201900922R. doi: 10.1096/fj.201900922R. [Epub ahead of print]

PMID:
31284764
2.

IL-10 mediates the immunoregulatory response in conjugated linoleic acid-induced regression of atherosclerosis.

McCarthy C, Duffy MM, Mooney D, James WG, Griffin MD, Fitzgerald DJ, Belton O.

FASEB J. 2013 Feb;27(2):499-510. doi: 10.1096/fj.12-215442. Epub 2012 Oct 15.

PMID:
23070607
3.

Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosis.

Bruen R, Curley S, Kajani S, Crean D, O'Reilly ME, Lucitt MB, Godson CG, McGillicuddy FC, Belton O.

Cardiovasc Diabetol. 2017 Nov 6;16(1):143. doi: 10.1186/s12933-017-0626-3.

4.

Liraglutide Attenuates Preestablished Atherosclerosis in Apolipoprotein E-Deficient Mice via Regulation of Immune Cell Phenotypes and Proinflammatory Mediators.

Bruen R, Curley S, Kajani S, Lynch G, O'Reilly ME, Dillon ET, Brennan EP, Barry M, Sheehan S, McGillicuddy FC, Belton O.

J Pharmacol Exp Ther. 2019 Sep;370(3):447-458. doi: 10.1124/jpet.119.258343. Epub 2019 Jul 3.

PMID:
31270216
5.

Conjugated linoleic acid targets β2 integrin expression to suppress monocyte adhesion.

de Gaetano M, Dempsey E, Marcone S, James WG, Belton O.

J Immunol. 2013 Oct 15;191(8):4326-36. doi: 10.4049/jimmunol.1300990. Epub 2013 Sep 18.

6.

Selective effect of conjugated linoleic acid isomers on atherosclerotic lesion development in apolipoprotein E knockout mice.

Arbonés-Mainar JM, Navarro MA, Guzmán MA, Arnal C, Surra JC, Acín S, Carnicer R, Osada J, Roche HM.

Atherosclerosis. 2006 Dec;189(2):318-27. Epub 2006 Mar 13.

PMID:
16530768
7.

Effects of conjugated linoleic acid isomers on monocyte, macrophage and foam cell phenotype in atherosclerosis.

Mooney D, McCarthy C, Belton O.

Prostaglandins Other Lipid Mediat. 2012 Aug;98(3-4):56-62. doi: 10.1016/j.prostaglandins.2011.12.006. Epub 2011 Dec 31. Review.

PMID:
22230216
8.

The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE-/- mice and inhibits monocyte/macrophage recruitment.

Xiong W, Wang X, Dai D, Zhang B, Lu L, Tao R.

Thromb Haemost. 2017 Jan 26;117(2):401-414. doi: 10.1160/TH16-06-0475. Epub 2016 Nov 10.

PMID:
27831589
9.

Conjugated linoleic acid induces an atheroprotective macrophage MΦ2 phenotype and limits foam cell formation.

de Gaetano M, Alghamdi K, Marcone S, Belton O.

J Inflamm (Lond). 2015 Feb 19;12:15. doi: 10.1186/s12950-015-0060-9. eCollection 2015.

10.

10,12 Conjugated Linoleic Acid-Driven Weight Loss Is Protective against Atherosclerosis in Mice and Is Associated with Alternative Macrophage Enrichment in Perivascular Adipose Tissue.

Kanter JE, Goodspeed L, Wang S, Kramer F, Wietecha T, Gomes-Kjerulf D, Subramanian S, O'Brien KD, den Hartigh LJ.

Nutrients. 2018 Oct 3;10(10). pii: E1416. doi: 10.3390/nu10101416.

11.

Atheroprotective effects of conjugated linoleic acid.

Bruen R, Fitzsimons S, Belton O.

Br J Clin Pharmacol. 2017 Jan;83(1):46-53. doi: 10.1111/bcp.12948. Epub 2016 May 7. Review.

12.

Conjugated linoleic acid suppresses the migratory and inflammatory phenotype of the monocyte/macrophage cell.

McClelland S, Cox C, O'Connor R, de Gaetano M, McCarthy C, Cryan L, Fitzgerald D, Belton O.

Atherosclerosis. 2010 Jul;211(1):96-102. doi: 10.1016/j.atherosclerosis.2010.02.003. Epub 2010 Feb 10.

PMID:
20223456
13.

Conjugated linoleic acid isomers have no effect on atherosclerosis and adverse effects on lipoprotein and liver lipid metabolism in apoE-/- mice fed a high-cholesterol diet.

Cooper MH, Miller JR, Mitchell PL, Currie DL, McLeod RS.

Atherosclerosis. 2008 Oct;200(2):294-302. doi: 10.1016/j.atherosclerosis.2007.12.040. Epub 2008 Feb 15.

PMID:
18280484
14.

SorLA modulates atheroprotective properties of CLA by regulating monocyte migration.

McCarthy C, O'Gaora P, James WG, de Gaetano M, McClelland S, Fitzgerald DJ, Belton O.

Atherosclerosis. 2010 Dec;213(2):400-7. doi: 10.1016/j.atherosclerosis.2010.09.025. Epub 2010 Oct 20. Erratum in: Atherosclerosis. 2011 May;216(1):250.

PMID:
20970138
15.

Profound resolution of early atherosclerosis with conjugated linoleic acid.

Toomey S, Harhen B, Roche HM, Fitzgerald D, Belton O.

Atherosclerosis. 2006 Jul;187(1):40-9. Epub 2005 Sep 22.

PMID:
16182300
16.

AMP-activated protein kinase α1 promotes atherogenesis by increasing monocyte-to-macrophage differentiation.

Zhang M, Zhu H, Ding Y, Liu Z, Cai Z, Zou MH.

J Biol Chem. 2017 May 12;292(19):7888-7903. doi: 10.1074/jbc.M117.779447. Epub 2017 Mar 22.

17.

MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice.

Du F, Yu F, Wang Y, Hui Y, Carnevale K, Fu M, Lu H, Fan D.

Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):759-67. doi: 10.1161/ATVBAHA.113.302701. Epub 2014 Feb 6.

18.
19.

Melanocortin 1 Receptor Deficiency Promotes Atherosclerosis in Apolipoprotein E-/- Mice.

Rinne P, Kadiri JJ, Velasco-Delgado M, Nuutinen S, Viitala M, Hollmén M, Rami M, Savontaus E, Steffens S.

Arterioscler Thromb Vasc Biol. 2018 Feb;38(2):313-323. doi: 10.1161/ATVBAHA.117.310418. Epub 2017 Dec 28.

20.

Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.

Horio E, Kadomatsu T, Miyata K, Arai Y, Hosokawa K, Doi Y, Ninomiya T, Horiguchi H, Endo M, Tabata M, Tazume H, Tian Z, Takahashi O, Terada K, Takeya M, Hao H, Hirose N, Minami T, Suda T, Kiyohara Y, Ogawa H, Kaikita K, Oike Y.

Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):790-800. doi: 10.1161/ATVBAHA.113.303116. Epub 2014 Feb 13.

PMID:
24526691

Supplemental Content

Support Center